SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/C16212973186E9F8AC3C416B86F169DA68F91FACE307F07FCD1FF88FE816164ABB260232B96364B2ACD6291E20E47E37>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/C16212973186E9F8AC3C416B86F169DA68F91FACE307F07FCD1FF88FE816164ABB260232B96364B2ACD6291E20E47E37
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/C16212973186E9F8AC3C416B86F169DA68F91FACE307F07FCD1FF88FE816164ABB260232B96364B2ACD6291E20E47E37
http://www.w3.org/2000/01/rdf-schema#comment
"Finding suggests that therapies directed against ILK and its downstream signaling targets may have the potential to enhance the efficacy of gemcitabine-based chemotherapy."
xsd:string
http://purl.uniprot.org/uniprot/#_85145175010E836FCEF6D106AA6CB984A3BE3F6EA849D925682DDDF4322B9C4B49DD2AA51C47EF288FD002F6CC890E89
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/C16212973186E9F8AC3C416B86F169DA68F91FACE307F07FCD1FF88FE816164ABB260232B96364B2ACD6291E20E47E37
http://purl.uniprot.org/uniprot/V9HWF0
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C16212973186E9F8AC3C416B86F169DA68F91FACE307F07FCD1FF88FE816164ABB260232B96364B2ACD6291E20E47E37
http://purl.uniprot.org/uniprot/#_V9HWF0-mappedCitation-15867245
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C16212973186E9F8AC3C416B86F169DA68F91FACE307F07FCD1FF88FE816164ABB260232B96364B2ACD6291E20E47E37